FibroGen, Inc. Settlement

Claim Deadline: June 12, 2024

Settlement Fund: $28,500,000

Settlement Class

All persons who purchased or acquired FibroGen securities, including options, between December 20, 2018 through July 15, 2021, inclusive.   

Important Documents

Settlement Status

Preliminarily Approved

Class Period

December 19, 2018 - October 13, 2021

Settlement Hearing Date

May 16, 2024

Opt-Out Deadline

April 18, 2024

Claims Admin

JND Legal Administration
P.O. Box 91482 Seattle, WA 98111

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.